FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI
- Country
- Italy
- Type
- Beneficiary
- Website
- www.istitutotumori.mi.it
- Grants received
- 47
Funding record
- 47 grants on record
- €17,900,089.79 awarded in total
- 2008–2025 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
- Horizon Europe Framework Programme
- Seventh Framework Programme
- Horizon 2020 Framework Programme
- European Research Council
12 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- INSTITUT GUSTAVE ROUSSY
- DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- KAROLINSKA INSTITUTET
- STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS
- EUROPEAN CANCER ORGANISATION
- OSLO UNIVERSITETSSYKEHUS HF
- ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
Calls from this organisation
No published calls from this organisation.
Grants received
- Prediction and prevention of late effects in AYA cancer survivors – An effort to understand, predict and prevent late effects in AYAs 15-39 years of age, with a focus on fertility and gonadal toxicity
- Validated non-invasive liquid biopsy tests for cancer PREDIction in LYNCH Syndrome
- Risk assessment Tools for severe side Effects after breasT Radiotherapy: radiation safety through biological extended models and dIgital twinS
- Bone Marrow-on-Chip as smart sensor of lung cancer relapse
- FCAECC Fellowship programme for talented researchers in cancer
- A PRAGMATIC CLINICAL STUDY OF NEOADJUVANT CHEMOTHERAPY FOLLOWED BY SURGERY VERSUS SURGERY ALONE FOR PATIENTS WITH HIGH RISK RETROPERITONEAL SARCOMA
- IMAGING AND ADVANCED GUIDANCE FOR WORKFLOW OPTIMIZATION IN INTERVENTIONAL ONCOLOGY
- COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE
- First line randomized study platform to optimize treatment in patients with metastatic renal cell carcinoma
- Establishing of Cancer Mission Hubs: Networks and Synergies
- Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe
- On-chip tomographic microscopy: a paraDIgm Shift for RevolUtionizing lab-on-a-chiP bioimaging technology
- THE STRONG-AYA INITIATIVE: IMPROVING THE FUTURE OF YOUNG ADULTS WITH CANCER
- Intelligent Ecosystem to improve the governance, the sharing and the re-use of health Data for Rare Cancers
- Developing and implementing innovative Patient-Centred Care Pathways for cancer patients
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.